Alkem Lab: Maintain ‘buy’, revise price target to Rs 3,361

[ad_1]


India sales were healthy in the quarter and were up 17% YoY. As per management, Alkem could get good traction in 1QFY22 for Vitamins/Minerals, Antacids and Antibiotics business, which is now back to normal levels.

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Polynion

Binance Prediction

Metamask

papamiaspizza.com